drugset / Trial / NCT03024476

Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance

NCT03024476

RandomizedParallel-groupOpen-labelTreatment

Summary

BOSS-Trial I is a phase 2 clinical trial with the following objectives; 1. to prove the feasibility of a Bluetooth-equipped sphygmomanometer system in real-world clinical practice and wireless connection to the main server; 2. to prove the feasibility of the BP management strategy, including the pre-specified BP range, BP management algorithm, and behavioral; and 3. to gather information for the phase 3 trial including BP variability indices and their potentials as a treatment guidance.

Timeline

Start
2016-09-01
Primary completion
2017-12-07
Completion
2017-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Hydrochlorothiazide Unknown 12.5 mg
Subject Olmesartan Other / unclassified 20 mg
Subject Olmesartan Other / unclassified 40 mg